APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases
R Fernández-Calle, SC Konings… - Molecular …, 2022 - Springer
ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …
polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of …
Protein S-sulfhydration: unraveling the prospective of hydrogen sulfide in the brain, vasculature and neurological manifestations
Hydrogen sulfide (H 2 S) and hydrogen polysulfides (H 2 S n) are essential regulatory
signaling molecules generated by the entire body, including the central nervous system …
signaling molecules generated by the entire body, including the central nervous system …
Role of SUMOylation in neurodegenerative diseases
N Mandel, N Agarwal - Cells, 2022 - mdpi.com
Neurodegenerative diseases (NDDs) are irreversible, progressive diseases with no effective
treatment. The hallmark of NDDs is the aggregation of misfolded, modified proteins, which …
treatment. The hallmark of NDDs is the aggregation of misfolded, modified proteins, which …
Proteomic characterization of post-translational modifications in drug discovery
L Zhai, K Chen, B Hao, M Tan - Acta Pharmacologica Sinica, 2022 - nature.com
Protein post-translational modifications (PTMs), which are usually enzymatically catalyzed,
are major regulators of protein activity and involved in almost all celluar processes …
are major regulators of protein activity and involved in almost all celluar processes …
PAD2: A potential target for tumor therapy
Abstract Peptide arginine deiminase 2 (PAD2) catalyzes the conversion of arginine residues
on target proteins to citrulline residues in the presence of calcium ions. This particular …
on target proteins to citrulline residues in the presence of calcium ions. This particular …
Triaging between post-translational modification of cell cycle regulators and their therapeutics in neurodegenerative diseases
Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and
Huntington's disease, present challenges in healthcare because of their complicated …
Huntington's disease, present challenges in healthcare because of their complicated …
SUMOylation of Rho-associated protein kinase 2 induces goblet cell metaplasia in allergic airways
D Tan, M Lu, Y Cai, W Qi, F Wu, H Bao, M Qv… - Nature …, 2023 - nature.com
Allergic asthma is characterized by goblet cell metaplasia and subsequent mucus
hypersecretion that contribute to the morbidity and mortality of this disease. Here, we explore …
hypersecretion that contribute to the morbidity and mortality of this disease. Here, we explore …
Lactylation may be a novel posttranslational modification in inflammation in neonatal hypoxic-ischemic encephalopathy
Y Zhou, L Yang, X Liu, H Wang - Frontiers in pharmacology, 2022 - frontiersin.org
Perinatal hypoxia-ischemia remains the most common cause of acute neonatal brain injury
and is associated with a high death rate and long-term neurological abnormalities such as …
and is associated with a high death rate and long-term neurological abnormalities such as …
Protein lipidation in health and disease: molecular basis, physiological function and pathological implication
Y Yuan, P Li, J Li, Q Zhao, Y Chang, X He - Signal Transduction and …, 2024 - nature.com
Posttranslational modifications increase the complexity and functional diversity of proteins in
response to complex external stimuli and internal changes. Among these, protein lipidations …
response to complex external stimuli and internal changes. Among these, protein lipidations …
The cGAS-STING pathway: post-translational modifications and functional implications in diseases
J Liu, K Rui, N Peng, H Luo, B Zhu, X Zuo, L Lu… - Cytokine & growth factor …, 2022 - Elsevier
Recent studies have illustrated the functional significance of DNA recognition in the
activation of innate immune responses among a variety of diseases. The cyclic GMP-AMP …
activation of innate immune responses among a variety of diseases. The cyclic GMP-AMP …